Usher 1F Collaborative is a U.S. nonprofit foundation whose mission is to fund medical research to save or restore the vision of those with Usher Syndrome type 1F. When we began in 2013, there was no research specific to Usher 1F. Since then, patients and families working together with scientists have brought about the development of gene, drug, and stem cell therapies at eight research labs around the world. If you or a family member has Usher 1F, please join us in our work to find a cure. Visit our website at https://www.usher1f.org and email us at info@usher1f.org
Here is a list of conditions this partner raises awareness and advocacy for:
The Usher 1F Collaborative has recently announced the opening of registration for its scientific conference titled “Therapeutic Strategies for Large Protein Coding Genes in Usher
Welcome to the Rare Classroom, a new series from Patient Worthy. Rare Classroom is designed for the curious reader who wants to get informed on
Genetic Counselors are an incredible resource – they can help assess your risk of developing a condition, the risk of your children inheriting a condition,
In a story for Drug Development & Delivery, the CEO of the biotechnology company ProQR, Daniel de Boer, recently sat down for an interview. In
According to a story from newton.wickedlocal.com, the first time that mother Melissa Chaikof realized that something was wrong with her oldest doctor was many years
-300x300.jpg)
After twenty-two years physician Huang Chun-jung finally learned why his vision and hearing have fallen to thirty percent of normalcy, thanks to research conducted by
© Copyright Patient Worthy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
